Achia Nemet, Raimo Tuuminen, Tzadok Yona, Gilad Plopsky, Michal Katz, Natali Glinkin, Olga Lelchuk, Joseph Pikkel
{"title":"CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Predicting Visual Acuity Outcomes Following Retinal Vein Occlusion.","authors":"Achia Nemet, Raimo Tuuminen, Tzadok Yona, Gilad Plopsky, Michal Katz, Natali Glinkin, Olga Lelchuk, Joseph Pikkel","doi":"10.1155/2024/3054783","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To find whether the CHA<sub>2</sub>DS<sub>2</sub>-VASc score, a system for stratifying stroke risk among patients with atrial fibrillation, correlates with visual acuity prognosis following retinal vein occlusion (RVO). <b>Participants and Methods:</b> This retrospective study included 83 eyes of 83 patients with a diagnosis of branch or central RVO between June 2017 and August 2022 with at least 12 months of follow-up in Assuta Ashdod Medical Center, Ashdod, Israel. The patients were divided into three groups, with CHA<sub>2</sub>DS<sub>2</sub>-VASc scores of 0-2 (<i>N</i> = 31), 3-5 (<i>N</i> = 45), or 6-9 (<i>N</i> = 7). The change in best-corrected visual acuity (BCVA) between the groups was examined about 1 year after the presentation of RVO. <b>Results:</b> The patient mean age was 67.9 ± 13.8 years; 38.6% were women. The mean visual acuity was 0.83 ± 0.67 LogMAR units at the first admission and 0.78 ± 0.80 LogMAR units at the last visit. Patients with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score from 6 to 9 had a significantly poorer BCVA prognosis at 1-year (+0.60 ± 0.94 [-0.27, 1.47] LogMAR units) compared to groups with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score from 3 to 5 (-0.01 ± 0.65 [-0.20, 0.19] LogMAR units) and a CHA<sub>2</sub>DS<sub>2</sub>-VASc score from 0 to 2 (-0.12 ± 0.59 [-0.33, 0.10] LogMAR units) (<i>p</i> = 0.038). <b>Conclusions:</b> Following RVO, patients with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 6 or higher had a worse prognosis in their visual acuity than patients with a lower score.</p>","PeriodicalId":16674,"journal":{"name":"Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519066/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2024/3054783","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To find whether the CHA2DS2-VASc score, a system for stratifying stroke risk among patients with atrial fibrillation, correlates with visual acuity prognosis following retinal vein occlusion (RVO). Participants and Methods: This retrospective study included 83 eyes of 83 patients with a diagnosis of branch or central RVO between June 2017 and August 2022 with at least 12 months of follow-up in Assuta Ashdod Medical Center, Ashdod, Israel. The patients were divided into three groups, with CHA2DS2-VASc scores of 0-2 (N = 31), 3-5 (N = 45), or 6-9 (N = 7). The change in best-corrected visual acuity (BCVA) between the groups was examined about 1 year after the presentation of RVO. Results: The patient mean age was 67.9 ± 13.8 years; 38.6% were women. The mean visual acuity was 0.83 ± 0.67 LogMAR units at the first admission and 0.78 ± 0.80 LogMAR units at the last visit. Patients with a CHA2DS2-VASc score from 6 to 9 had a significantly poorer BCVA prognosis at 1-year (+0.60 ± 0.94 [-0.27, 1.47] LogMAR units) compared to groups with a CHA2DS2-VASc score from 3 to 5 (-0.01 ± 0.65 [-0.20, 0.19] LogMAR units) and a CHA2DS2-VASc score from 0 to 2 (-0.12 ± 0.59 [-0.33, 0.10] LogMAR units) (p = 0.038). Conclusions: Following RVO, patients with a CHA2DS2-VASc score of 6 or higher had a worse prognosis in their visual acuity than patients with a lower score.
期刊介绍:
Journal of Ophthalmology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the anatomy, physiology and diseases of the eye. Submissions should focus on new diagnostic and surgical techniques, instrument and therapy updates, as well as clinical trials and research findings.